1型糖尿病高危HLA-DR和HLA-DQ多态性与婴儿期生长及IGF-I水平的差异关联:剑桥婴儿生长研究
该前瞻性出生队列研究纳入2229名新生儿,对612名儿童进行HLA区域单核苷酸多态性(rs17426593、rs2187668、rs7454108)分型。纵向模型显示rs2187668(DR3)次要等位基因与更快的线性生长及IGF-I、IGFBP-3浓度升高相关;横断面分析显示rs7454108(DQ8)和rs17426593(DR4)分别与12月龄较低IGF-I和24月龄较大皮褶厚度相关。
要点
- DR3次要等位基因与婴儿期更快的线性生长及IGF-I、IGFBP-3升高相关。
- DQ8次要等位基因与12月龄时较低的IGF-I浓度相关。
- DR4次要等位基因与24月龄时较大的皮褶厚度相关。
核心结论
- DR4、DR3和DQ8等位基因与婴儿生长指标及IGF-I水平的关联存在差异,可能解释遗传高危队列中观察到的异质性生长轨迹。
- 这些发现可能提示HLA conferred 1型糖尿病风险涉及不同的内分泌通路机制。
研究设计与样本
- 剑桥婴儿生长研究为前瞻性观察性出生队列,招募2229名新生儿进行婴儿期随访。
- 612名儿童有DNA可用于HLA区域单核苷酸多态性(rs17426593、rs2187668、rs7454108)分型。
- 采用多变量线性回归模型(横断面)和混合效应模型(纵向)在加性遗传效应下检验关联。
主要发现
- 纵向模型中,rs2187668(DR3)次要等位基因与更快的线性生长相关(P = 0.007),在男孩中更明显(P = 3 × 10-7),女孩中P = 0.07。
- rs2187668(DR3)次要等位基因还与婴儿期IGF-I(P = 0.002)和IGFBP-3(P = 0.003)浓度升高相关。
- 横断面分析中,rs7454108(DQ8)次要等位基因与12月龄时较低IGF-I浓度相关(P = 0.003)。
- rs17426593(DR4)次要等位基因与24月龄时较大皮褶厚度相关(P = 0.003)。
临床怎么用
- 在遗传高危婴儿中,应关注不同HLA等位基因携带者的生长轨迹和IGF-I水平差异。
- 对携带DR3等位基因的婴儿,尤其男孩,需注意监测线性生长和IGF-I变化。
- 对携带DQ8或DR4等位基因的婴儿,可分别关注12月龄IGF-I水平和24月龄皮褶厚度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study explored the link between HLA polymorphisms that predispose to type 1 diabetes and birth size, infancy growth, and/or circulating IGF-I in a general population-based birth cohort. RESEARCH DESIGN AND METHODS: The Cambridge Baby Growth Study is a prospective observational birth cohort study that recruited 2,229 newborns for follow-up in infancy. Of these, 612 children had DNA available for genotyping single nucleotide polymorphisms in the HLA region that capture the highest risk of type 1 diabetes: rs17426593 for DR4, rs2187668 for DR3, and rs7454108 for DQ8. Multivariate linear regression models at critical ages (cross-sectional) and mixed-effects models (longitudinal) were performed under additive genetic effects to test for associations between HLA polymorphisms and infancy weight, length, skinfold thickness (indicator of adiposity), and concentrations of IGF-I and IGF-binding protein-3 (IGFBP-3). RESULTS: In longitudinal models, the minor allele of rs2187668 tagging DR3 was associated with faster linear growth (P = 0.007), which was more pronounced in boys (P = 3 × 10-7) than girls (P = 0.07), and was also associated with increasing IGF-I (P = 0.002) and IGFBP-3 (P = 0.003) concentrations in infancy. Cross-sectionally, the minor alleles of rs7454108 tagging DQ8 and rs17426593 tagging DR4 were associated with lower IGF-I concentrations at age 12 months (P = 0.003) and greater skinfold thickness at age 24 months (P = 0.003), respectively. CONCLUSIONS: The variable associations of DR4, DR3, and DQ8 alleles with growth measures and IGF-I levels in infants from the general population could explain the heterogeneous growth trajectories observed in genetically at-risk cohorts. These findings could suggest distinct mechanisms involving endocrine pathways related to the HLA-conferred type 1 diabetes risk.
引用
- Eleftheriou A, Petry CJ, Hughes IA, et al. The High-Risk Type 1 Diabetes HLA-DR and HLA-DQ Polymorphisms Are Differentially Associated With Growth and IGF-I Levels in Infancy: The Cambridge Baby Growth Study. Diabetes Care. 2021. PMID: 34172490. doi:10.2337/dc20-2820
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。